FR2196162B1 - - Google Patents

Info

Publication number
FR2196162B1
FR2196162B1 FR7329860A FR7329860A FR2196162B1 FR 2196162 B1 FR2196162 B1 FR 2196162B1 FR 7329860 A FR7329860 A FR 7329860A FR 7329860 A FR7329860 A FR 7329860A FR 2196162 B1 FR2196162 B1 FR 2196162B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7329860A
Other languages
French (fr)
Other versions
FR2196162A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47082574A external-priority patent/JPS5238559B2/ja
Priority claimed from JP48039354A external-priority patent/JPS49125359A/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2196162A1 publication Critical patent/FR2196162A1/fr
Application granted granted Critical
Publication of FR2196162B1 publication Critical patent/FR2196162B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7329860A 1972-08-17 1973-08-16 Expired FR2196162B1 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP47082574A JPS5238559B2 (enExample) 1972-08-17 1972-08-17
JP48039354A JPS49125359A (enExample) 1973-04-05 1973-04-05
ZA00741280A ZA741280B (en) 1972-08-17 1974-02-26 Thiazole derivatives

Publications (2)

Publication Number Publication Date
FR2196162A1 FR2196162A1 (enExample) 1974-03-15
FR2196162B1 true FR2196162B1 (enExample) 1977-01-28

Family

ID=27290112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7329860A Expired FR2196162B1 (enExample) 1972-08-17 1973-08-16

Country Status (10)

Country Link
US (1) US3932400A (enExample)
CA (1) CA991640A (enExample)
CH (1) CH581640A5 (enExample)
DE (1) DE2341753C2 (enExample)
DK (1) DK149893C (enExample)
FR (1) FR2196162B1 (enExample)
GB (1) GB1435139A (enExample)
NL (1) NL179733C (enExample)
SE (1) SE421615B (enExample)
ZA (1) ZA741280B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
US4260609A (en) * 1977-06-01 1981-04-07 Merck & Co., Inc. Di- and tri- substituted thiazoles
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
KR100668539B1 (ko) 2002-08-19 2007-01-16 화이자 프로덕츠 인크. 과증식성 질환에 대한 조합요법
CA2526730A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド (3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
WO2007086980A2 (en) * 2005-11-10 2007-08-02 Duke University Methods of determining the risk of developing coronary artery disease
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EA200801716A1 (ru) * 2006-01-18 2009-04-28 Амген Инк. Тиазольные соединения и их применение
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
AR063469A1 (es) * 2006-07-14 2009-01-28 Ranbaxy Lab Ltd Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104530033B (zh) * 2014-12-26 2017-07-07 江西百神药业股份有限公司 一种盐酸阿罗洛尔的制备工艺新方法
CN105646472A (zh) * 2016-02-29 2016-06-08 山东齐都药业有限公司 一种盐酸阿罗洛尔的制备方法
MA54261B1 (fr) 2019-01-18 2025-03-28 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA599475A (en) * 1960-06-07 W. Harman Marion Aminoethylthiazoles
US2221147A (en) * 1938-11-18 1940-11-12 Goodrich Co B F Preparation of aminated esters of sulphydryl compounds
US3228952A (en) * 1962-06-27 1966-01-11 Dow Chemical Co Thiazole thioethers
US3158623A (en) * 1963-03-01 1964-11-24 Abbott Lab 5-nitro-2-furylthioamide
BE790569A (fr) * 1971-10-27 1973-04-26 Syntex Corp Agents cardiovasculaires a base de thiazoles

Also Published As

Publication number Publication date
AU5928173A (en) 1975-02-20
NL7311248A (enExample) 1974-02-19
GB1435139A (en) 1976-05-12
CA991640A (en) 1976-06-22
NL179733B (nl) 1986-06-02
US3932400A (en) 1976-01-13
ZA741280B (en) 1975-03-26
DE2341753C2 (de) 1982-12-09
FR2196162A1 (enExample) 1974-03-15
SE421615B (sv) 1982-01-18
DE2341753A1 (de) 1974-02-21
DK149893B (da) 1986-10-20
DK149893C (da) 1987-04-21
NL179733C (nl) 1986-11-03
CH581640A5 (enExample) 1976-11-15

Similar Documents

Publication Publication Date Title
FR2196162B1 (enExample)
FR2205431A1 (enExample)
CS162796B2 (enExample)
JPS4881151A (enExample)
JPS5420838Y2 (enExample)
JPS5235854B2 (enExample)
JPS4970791U (enExample)
CS165031B1 (enExample)
CS159966B1 (enExample)
CS165814B1 (enExample)
JPS4955460U (enExample)
CS165827B1 (enExample)
CS159521B1 (enExample)
JPS4884791U (enExample)
CS156981B1 (enExample)
JPS48101862A (enExample)
CS155035B1 (enExample)
CS165605B1 (enExample)
JPS4955584U (enExample)
CS155023B1 (enExample)
CS154740B1 (enExample)
CS154178B1 (enExample)
CS163448B1 (enExample)
JPS48108868U (enExample)
CS162070B1 (enExample)